GL1X · GenesisL1 explorer

MolNFT v1 · #88320 · protein

Creating novel F1 inhibitors through fragment based lead generation and structure aided drug design

4CR5 · Coagulation factor xia: “Creating novel F1 inhibitors through fragment based lead generation and structure aided drug design”. X-ray diffraction, 2 ligands (0TU, SO4), 2 pockets (best druggability 0.52). MolNFT v1 #88320 on…

PDB
4CR5
Type
protein
Length
238 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Coagulation factor xia
EC
3.4.21.27
UniProt
P03951
Ligands
0TU, SO4
Pockets
2 · best druggability 0.52

Structure

x-ray diffraction · 1 distinct chain · 14% helix, 34% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACoagulation factor xia (EC 3.4.21.27)protein23814% helix, 34% strandP03951

Ligands and binding sites

  • 0TU · 6-chloroquinolin-2(1H)-one · ligand · chains A
  • SO4 · Sulfate ion · ion · 7 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11820.520.78290TU, SO4
2950.410.7717empty

Modifications

Observed in the structure: 4 disulfide (disulfide).

Compared structures

  • 4CR5 · Creating novel F1 inhibitors through fragment based lead generation and structure aided… · the same entry in another collection · chain A against A, TM-score 1.00
  • P03951 · AlphaFold monomer V2.0 prediction for coagulation factor XI (P03951) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.